Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001708599-25-000007
Filing Date
2025-01-15
Accepted
2025-01-15 16:17:50
Documents
1
Period of Report
2025-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1736975863.html 3  
1 FORM 3 wk-form3_1736975863.xml 3 1555
  Complete submission text file 0001708599-25-000007.txt   3146
Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Business Address
WILSON KAREN J (Reporting) CIK: 0001267490 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38519 | Film No.: 25533119

Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)